Relievant Medsystems, Inc. develops treatment and technologies for chronic back pain. Its Intracept System solution is a minimally invasive procedure that uses radiofrequency energy delivered into the vertebral body of the spine to ablate the basivertebral nerve. Relievant Medsystems was founded by James C. Peacock, Jeffrey Charles Lotz, and Rex Peters in 2004 and is headquartered in Redwood City, CA.

AxoGen, Inc. engages in the development of treatment options for the repair of peripheral nerve injuries. It offers AVANCE Nerve Graft, a human allograft nerve that is used for the repair, replacement, and reconstruction of damaged peripheral nerves. The company accepts orders through phone, fax, or email. It serves surgeons. AxoGen has a strategic tissue recovery partnership with American Tissue Services Foundation (ATSF). The company was founded in 2002 and is based in Alachua, Florida.

BSN Medical, Inc. manufactures and supplies medical equipment. Its brands include Actimove, Comprilan, Delta-Lite, Specialist and Tensoplast. The company is headquartered in Charlotte, NC.

Hoolest Performance Technologies develops drug-free technologies to reduce anxiety and enhance human performance. The company offers the P57 ONE, a novel non-invasive electrical nerve stimulation device. It works by applying small electrical impulses that stimulate a branch of the vagus nerve around the ear. This activates the body’s own response to induce a calm and focused state. It was founded in 2017 and is headquartered in Phoenix, Arizona.

Stratus Medical is a medical device company focused on reducing pain and suffering and improving the quality of life for chronic pain patients through innovation. Our leading product is the Nimbus RF Multitined Expandable Electrode that was developed to address the unmet need for an easy to use, efficient, cost-effective RF device that provides a large volume and optimally shaped lesion, which interventional pain specialists, orthopedic surgeons and neurosurgeons can use to treat pain. Nimbus has been shown to reduce procedural time and increase efficiency for hospitals and surgery centers where Nimbus is utilized. The Nimbus device is FDA cleared and CE marked. Nimbus has been utilized in over 100,000 patient treatments in Australia, Brazil, Canada, United Kingdom, United States and other countries.

Incept is an effective vehicle for promotion and advancement of technology innovation and entrepreneurship with a primary focus in the life-sciences space, and occasional involvement in unique and select information-technology opportunities, where Incept’s management and financing depth is found to be transferable to the IT space. Incept’s mission is to innovate leadership product lines, meeting the important unmet technological needs of the medical technology space while cultivating leaders who build superb companies focused on growth and creation of shareholder value.

Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

EBT Medical is a clinical-stage startup developing disruptive neuromodulation therapies for pelvic health disorders. EBT was founded based on scientific discoveries made at the University of Toronto and successfully incubated by their startup program, which has helped create over 500 companies in the last 10 years.

Tulavi Therapeutics is a biotechnology company that is dedicated to developing new therapies to treat neurally mediated diseases. The company's solution is dedicated to developing therapies that directly target the nerves to prevent and/or treat aberrant neural reflex arcs in the peripheral and visceral disease that can be administered through surgical and interventional approaches, enabling physicians to treat such diseases in a better way. The company was founded in 2018 and is headquartered in Mountain View, California.

Spinal Modulation, Inc. provides medical devices research and development services. The company is based in Menlo Park, California. According to the 2002 Health Assessment on the Prevalence of Chronic Pain, severe chronic pain, as defined by the International Association for the Study of Pain, is prevalent in 10 to 13% of the adult population. Limited treatment options exist for these patients and the burden to the healthcare system is unsustainable. The Spinal Modulation AxiumTM Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomies such as the back and foot. By stimulating the DRG, therapy can be adjusted to cover either broad or specific areas of pain throughout the torso and legs, while limiting uncomfortable postural effects typically experienced with other spinal cord stimulators.

DePuy Synthes Products, Inc. develops and markets medical products. It offers distal volar Radius, which is designed to treat distal radius fractures, dorsal endoplate, an invasive dorsal nail plate that provides fixed angle support and intramedullary locked fixation with a duplicate and reproducible surgical procedure, spatial subchondral support plate, which is used to treat proximal humeral fractures and Small Bone Fixation System, a percutaneous locked intramedullary nail system for metacarpals and the phalanges. The company was founded on June 22, 2004 and is headquartered in Wilmington, DE.

Advanced Neuromodulation Systems, Inc. manufactured, designed, developed and marketed spinal cord stimulation devices. Their products included implantable neurostimulation devices, which deliver electric current directly to targeted nerves and implantable drug pumps. The company was registered in May 3, 1979 and was headquartered in St. Paul, MN.

Fempulse is a high tech company that manufactures a small subset of products aimed at combating overactive bladder syndrome.

Nimbus Concepts, LLC operates in the biotechnology sector. The company was incorporated in 2011 and is based in Denver, Colorado.

SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure.

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension. Its technology involves endovascular catheters to provide an efficacious, durable, cost-effective, and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.

Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries. Neuraptive was founded to commercialize innovative technology from the University of Texas. Its franchise therapeutics product is designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. Founded in 2016, Neuraptive Therapeutics is headquartered in Lafayette, Colorado.

Kyphon produces medical devices to treat and restore spinal anatomy using minimally invasive technology. It is engaged in developing surgical systems, apparatus and methods for mixing materials, instruments and methods for forming a cavity, and other products related to its industry. Kyphon operates as a subsidiary of Medtronic, Inc.It is based in Switzerland.